{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:12Z","timestamp":1761541092990},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.semradonc.2012.03.006","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T03:41:59Z","timestamp":1339213319000},"page":"214-219","source":"Crossref","is-referenced-by-count":14,"title":["Retreatment of Recurrent Head and Neck Cancer in a Previously Irradiated Field"],"prefix":"10.1016","volume":"22","author":[{"given":"Stuart J.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey J.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2012.03.006_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hed.20139","article-title":"Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas","volume":"27","author":"Taussky","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.semradonc.2012.03.006_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","article-title":"RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck","volume":"51","author":"Spencer","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib3","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","article-title":"Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of radiation therapy oncology group protocol 9911","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib4","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma","volume":"26","author":"Janot","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.20697","article-title":"Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck","volume":"30","author":"Spencer","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.semradonc.2012.03.006_bib6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2010.08.029","article-title":"Risk of carotid blowout after reirradiation of the head and neck: A systematic review","volume":"82","author":"McDonald","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.26084","article-title":"Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation","author":"Choe","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2012.03.006_bib8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.2008.20.0691","article-title":"Prognostic factors for survival after salvage reirradiation of head and neck cancer","volume":"27","author":"Tanvetyanon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2003.10.056","article-title":"Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer","volume":"59","author":"Machtay","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib10","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/annonc\/mdq785","article-title":"Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck","volume":"22","author":"Villaflor","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.annonc.a010793","article-title":"Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease","volume":"7","author":"Haraf","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib12","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1200\/JCO.1998.16.11.3556","article-title":"Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients","volume":"16","author":"De Crevoisier","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","article-title":"IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes","volume":"73","author":"Sulman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijrobp.2006.12.055","article-title":"Salvage re-irradiation for recurrent head and neck cancer","volume":"68","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ijrobp.2008.10.042","article-title":"The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: Implications for defining the targets","volume":"74","author":"Popovtzer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib16","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hed.21663","article-title":"Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer","volume":"33","author":"Zwicker","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.semradonc.2012.03.006_bib17","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1002\/cncr.25305","article-title":"Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer","volume":"116","author":"Sher","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2012.03.006_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/hed.20786","article-title":"Outcomes following reirradiation of patients with head and neck cancer","volume":"30","author":"Goldstein","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.semradonc.2012.03.006_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2010.02.023","article-title":"Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer","volume":"80","author":"Chen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: Development of a new method for summarising adverse events of cancer treatment by the radiation therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2008.10.013","article-title":"Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer","volume":"74","author":"Roh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2009.06.070","article-title":"Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer","volume":"77","author":"Unger","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2010.04.027","article-title":"Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors","volume":"81","author":"Cengiz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/COC.0b013e3181dbb73e","article-title":"Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: A single institution matched case-control study","volume":"34","author":"Heron","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib25","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/cncr.25786","article-title":"Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer","volume":"117","author":"Kao","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2012.03.006_bib26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ijrobp.2009.09.003","article-title":"Initial results of a phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer","volume":"78","author":"Rusthoven","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00066-010-2149-7","article-title":"IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer","volume":"187","author":"Zwicker","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00066-009-2092-7","article-title":"Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck","volume":"185","author":"Balermpas","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2007.13.1706","article-title":"Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer","volume":"26","author":"Seiwert","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2012.03.006_bib30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2006.09.056","article-title":"Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer","volume":"67","author":"Cohen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib31","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ijrobp.2005.05.007","article-title":"Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma","volume":"63","author":"Van Waes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2006.09.044","article-title":"Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation","volume":"67","author":"Milas","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2012.03.006_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0360-3016(01)01671-6","article-title":"C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability","volume":"51","author":"Nasu","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib35","first-page":"701","article-title":"In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody","volume":"6","author":"Milas","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2012.03.006_bib36","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ijrobp.2004.02.050","article-title":"C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy","volume":"59","author":"Nakata","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2012.03.006_bib37","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2005.05.3850","article-title":"Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone?","volume":"24","author":"Wong","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429612000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429612000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T03:27:59Z","timestamp":1642390079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429612000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1053429612000252"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2012.03.006","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}